207 related articles for article (PubMed ID: 15383793)
1. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.
Pin RH; Reinblatt M; Fong Y
Ann Surg; 2004 Oct; 240(4):659-65; discussion 665-6. PubMed ID: 15383793
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen directed herpes viral oncolysis improves selectivity and activity in colorectal cancer.
Reinblatt M; Pin RH; Fong Y
Surgery; 2004 Sep; 136(3):579-84. PubMed ID: 15349105
[TBL] [Abstract][Full Text] [Related]
3. Utilizing tumor hypoxia to enhance oncolytic viral therapy in colorectal metastases.
Reinblatt M; Pin RH; Federoff HJ; Fong Y
Ann Surg; 2004 Jun; 239(6):892-9; discussion 899-902. PubMed ID: 15166969
[TBL] [Abstract][Full Text] [Related]
4. Employing tumor hypoxia to enhance oncolytic viral therapy in breast cancer.
Pin RH; Reinblatt M; Fong Y
Surgery; 2004 Aug; 136(2):199-204. PubMed ID: 15300180
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
6. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
7. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
8. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells.
He P; Tang ZY; Liu BB; Ye SL; Liu YK
J Cancer Res Clin Oncol; 1999; 125(2):77-82. PubMed ID: 10190313
[TBL] [Abstract][Full Text] [Related]
9. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.
Li W; Li DM; Chen K; Chen Z; Zong Y; Yin H; Xu ZK; Zhu Y; Gong FR; Tao M
BMC Cancer; 2012 Nov; 12():547. PubMed ID: 23173703
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia/hepatoma dual specific suicide gene expression plasmid delivery using bio-reducible polymer for hepatocellular carcinoma therapy.
Kim HA; Nam K; Lee M; Kim SW
J Control Release; 2013 Oct; 171(1):1-10. PubMed ID: 23830978
[TBL] [Abstract][Full Text] [Related]
11. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
13. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
[TBL] [Abstract][Full Text] [Related]
15. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
16. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
[TBL] [Abstract][Full Text] [Related]
17. Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors.
Ye X; Liang M; Meng X; Ren X; Chen H; Li ZY; Ni S; Lieber A; Hu F
Biochem Biophys Res Commun; 2003 Aug; 307(4):759-64. PubMed ID: 12878174
[TBL] [Abstract][Full Text] [Related]
18. The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma.
Hsieh YJ; Chen FD; Ke CC; Wang HE; Huang CJ; Hou MF; Lin KP; Gelovani JG; Liu RS
Mol Imaging Biol; 2012 Aug; 14(4):452-61. PubMed ID: 21796480
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
[TBL] [Abstract][Full Text] [Related]
20. α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy.
Peng YF; Shi YH; Ding ZB; Zhou J; Qiu SJ; Hui B; Gu CY; Yang H; Liu WR; Fan J
PLoS One; 2013; 8(2):e53072. PubMed ID: 23468839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]